Utilize este identificador para referenciar este registo: http://hdl.handle.net/10362/188915
Título: Continuous Production of Influenza VLPs Using IC-BEVS and Multi-Stage Bioreactors
Autor: Correia, Ricardo
Zotler, Taja
Ferraz, Francisco
Fernandes, Bárbara
Graça, Miguel
Pijlman, Gorben P.
Alves, Paula M.
Roldão, António
Palavras-chave: baculovirus vector design
continuous production
influenza HA-VLPs
insect cells
multi-stage bioreactors
Biotechnology
Bioengineering
Applied Microbiology and Biotechnology
Data: 17-Jan-2025
Resumo: The insect cell-baculovirus expression vector system (IC-BEVS) has been an asset to produce biologics for over 30 years. With the current trend in biotechnology shifting toward process intensification and integration, developing intensified processes such as continuous production is crucial to hold this platform as a suitable alternative to others. However, the implementation of continuous production has been hindered by the lytic nature of this expression system and the process-detrimental virus passage effect. In this study, we implemented a multi-stage bioreactor setup for continuous production of influenza hemagglutinin-displaying virus-like particles (HA-VLPs) using IC-BEVS. A setup consisting of one Cell Growth Bioreactor simultaneously feeding non-infected insect cells to three parallel Production Bioreactors operated at different residence times (RT) (18, 36, and 54 h) was implemented; Production Bioreactors were continuously harvested. Two insect cell lines (neutral pH–adapted High Five and Sf9) and two recombinant baculovirus (rBAC) constructs (one that originates from a bacmid, rBACbacmid, and another of non-bacteria origin, rBACflashbac) were tested. Combining rBACflashbac with Sf9 cells was the most efficient approach, allowing consistent HA-VLPs titers (34 ± 14 HA titer/mL) and rBAC titers (108–109 pfu/mL) throughout the period of continuous operation (20 days). Cell growth kinetics and viability varied across RT, and higher RT was associated with increased expression of HA-VLPs, independent of the cell line and rBAC used; RT of 54 h allowed to maximize titers. The presence of particles resembling HA-VLPs was confirmed by transmission electron microscopy throughout the continuous operation. This work showcases the implementation of a process for continuous production of a promising class of biotherapeutics (i.e., VLPs), and paves the way for establishing continuous, integrated setups using the IC-BEVS expression system.
Descrição: Funding Information: iNOVA4Health (UIDB/04462/2020 and UIDP/04462/2020), a program financially supported by Funda\u00E7\u00E3o para a Ci\u00EAncia e a Tecnologia (FCT)/Minist\u00E9rio da Ci\u00EAncia, Tecnologia e Ensino Superior, is acknowledged through national funds. Funding from INTERFACE Programme, through the Innovation, Technology and Circular Economy Fund (FITEC), is gratefully acknowledged. This work was supported by EU\u2010funded project \u201CEDUFLUVAC\u201D (FP7\u2010HEALTH\u20102013\u2010INNOVATION\u20101, GA n. 602640), \u201CTRANSVAC2\u201D (H2020\u2010INFRAIA\u20102016\u20102017, GA n. 730964), and \u201CADDovenom\u201D (H2020\u2010FETOPEN\u20102018\u20102020, GA n. 899670), and by FCT through the initiatives \u201CInvestigador FCT\u201D Program (IF/01704/2014), Exploratory Research and Development Project (IF/01704/2014/CP1229/CT0001), and PhD fellowships (Ricardo Correia\u2014SFRH/BD/134107/2017; B\u00E1rbara Fernandes\u2014SFRH/BD/138937/2018). Funding Information: The authors wish to thank Mafalda Dias for the support in designing the RT-qPCR primers, probes, and quantification standard; Alexandre B. Murad for the support in analytics; and Felipe Tapia from MPI, Germany, for the fruitful discussion regarding the design of the continuous process. iNOVA4Health (UIDB/04462/2020 and UIDP/04462/2020), a program financially supported by Funda\u00E7\u00E3o para a Ci\u00EAncia e a Tecnologia (FCT)/Minist\u00E9rio da Ci\u00EAncia, Tecnologia e Ensino Superior, is acknowledged through national funds. Funding from INTERFACE Programme, through the Innovation, Technology and Circular Economy Fund (FITEC), is gratefully acknowledged. This work was supported by EU-funded project \u201CEDUFLUVAC\u201D (FP7-HEALTH-2013-INNOVATION-1, GA n. 602640), \u201CTRANSVAC2\u201D (H2020-INFRAIA-2016-2017, GA n. 730964), and \u201CADDovenom\u201D (H2020-FETOPEN-2018-2020, GA n. 899670), and by FCT through the initiatives \u201CInvestigador FCT\u201D Program (IF/01704/2014), Exploratory Research and Development Project (IF/01704/2014/CP1229/CT0001), and PhD fellowships (Ricardo Correia\u2014SFRH/BD/134107/2017; B\u00E1rbara Fernandes\u2014SFRH/BD/138937/2018). Publisher Copyright: © 2025 The Author(s). Biotechnology and Bioengineering published by Wiley Periodicals LLC.
Peer review: yes
URI: http://hdl.handle.net/10362/188915
DOI: https://doi.org/10.1002/bit.28925
ISSN: 0006-3592
Aparece nas colecções:Home collection (ITQB)

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
Continuous_Production_of_Influenza_VLPs_Using_IC_BEVS.pdf2,6 MBAdobe PDFVer/Abrir


FacebookTwitterDeliciousLinkedInDiggGoogle BookmarksMySpace
Formato BibTex MendeleyEndnote 

Todos os registos no repositório estão protegidos por leis de copyright, com todos os direitos reservados.